Published in Pharmacology on January 01, 1978
Epilepsy, hyperalgesia, impaired memory, and loss of pre- and postsynaptic GABA(B) responses in mice lacking GABA(B(1)). Neuron (2001) 2.51
Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA. Br J Pharmacol (1976) 1.95
Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein. Acta Neuropathol (2000) 1.92
The pharmacology of 5-chloro-4-(2-imidazolin-2-yl-amino)-2,1,3-benzothiadiazole (DS 103-282), a novel myotonolytic agent. Arzneimittelforschung (1980) 1.63
Alterations in sleep-wakefulness cycle in rats following treatment with (+)-lysergic acid diethylamide (LSD-25). Br J Pharmacol (1971) 1.39
[Effects of D-lysergic acid diethylamide (LSD-25) and 2-bromo-D-lysergic acid diethylamide (BOL-148) on sleeping behavior in rats]. Naunyn Schmiedebergs Arch Pharmakol (1970) 1.31
Cognitive slowing in Parkinson's disease fails to respond to levodopa treatment: the 15-objects test. Neurology (1989) 1.01
In vivo pharmacological effects of ciclosporin and some analogues. Adv Pharmacol (1996) 0.93
Proceedings: CB 154 (2-bromo-alpha-ergokryptine, bromocriptin), a potential anti-Parkinson agent. Naunyn Schmiedebergs Arch Pharmacol (1974) 0.89
Proceedings: CF 25-397 (9, 10-didehydro-6-methyl-8beta-(2-pyridylthiomethyl) ergoline), a new central dopamine receptor agonist. Br J Pharmacol (1976) 0.88
Neuroleptic-induced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesias. Effects of clozapine, haloperidol, loxapine and chlorpromazine. Psychopharmacologia (1975) 0.86
Effect of clozapine on the metabolism of serotonin in rat brain. Psychopharmacologia (1976) 0.85
Effects of clozapine, thioridazine, perlapine and haloperidol on the metabolism of the biogenic amines in the brain of the rat. Psychopharmacologia (1975) 0.83
Measurement of cholecystokinin octapeptide-induced motility of rat antrum, pylorus, and duodenum in vitro. Am J Physiol (1983) 0.82
Alpha adrenergic control of growth hormone in adult male rats. Experientia (1976) 0.82
Effects of clozapine and other dibenzo-epines on central dopaminergic and cholinergic systems. Structure-activity relationships. Arzneimittelforschung (1977) 0.82
Neuropharmacological investigations with two ergot alkaloids, Hydergine and bromocriptine. Postgrad Med J (1976) 0.81
Adrenergic and dopaminergic control of growth hormone secretion in urethan anesthetized adult male rats. Horm Res (1978) 0.81
Mechanism of action of cholecystokinin octapeptide on rat antrum, pylorus, and duodenum. Am J Physiol (1983) 0.80
Structure-activity relationships of dopaminergic 5-hydroxy-2-aminotetralin derivatives with functionalized N-alkyl substituents. J Med Chem (1986) 0.80
[Pharmacological and neurochemical effects of clozapine (Leponex): new aspects in the drug therapy of schizophrenia]. Schweiz Med Wochenschr (1973) 0.80
[Dopamine-receptor stimulants in the treatment of Parkinson's disease (author's transl)]. Nervenarzt (1982) 0.79
Receptor dynamics: effect of repeated administration of desmethylimipramine on the noradrenergic systems in rat brain. Postgrad Med J (1981) 0.79
Two novel prolactin release-inhibiting 8 alpha-amino-ergolines. Experientia (1979) 0.79
Animal models for tardive dyskinesia: effects of thioridazine. Pharmakopsychiatr Neuropsychopharmakol (1977) 0.79
Effect of single and repeated administration of clozapine on the metabolism of dopamine and noradrenaline in the brain of the rat. Eur J Pharmacol (1974) 0.79
Biochemical, behavioural, and endocrine effects of CK 204-933, a novel 8 beta-ergolene. J Neural Transm (1987) 0.79
Inter-group aggression in mice: a new method for testing the effects of centrally active drugs. Psychopharmacologia (1975) 0.78
Spontaneous recovery from motor asymmetry in adult rats with 6-hydroxydopamine-induced partial lesions of the substantia nigra. Brain Res (1984) 0.77
Antiacetylcholine activities of psychoactive drugs: a comparison of the [3H]quinuclidinyl benzilate binding assay with conventional methods. J Pharm Pharmacol (1976) 0.77
Proceedings: A quantitative assessment of the effects of clonidine on pre-ganglionic sympathetic nerve activity in the cat. Br J Pharmacol (1974) 0.77
Extrapyramidal side-effects. Pharmacol Ther B (1979) 0.77
SDZ GLC 756, a novel octahydrobenzo[g]quinoline derivative exerts opposing effects on dopamine D1 and D2 receptors. J Neural Transm (Vienna) (1996) 0.77
Effect of long term hydergine treatment on the age-dependent loss of mossy fibers and of granule cells in the rat hippocampus. Arch Gerontol Geriatr (2004) 0.76
Pharmacological properties of SDZ 208-912: a potential high potency, non-classical neuroleptic. Pharmacopsychiatry (1988) 0.76
Inhibition of reserpine-induced PGO waves in the cat by ergot derivatives. Experientia (1978) 0.76
Polygraphic sleep studies in rats and humans: their use in psychopharmacological research. Arzneimittelforschung (1976) 0.76
Proceedings: Alterations in the sleep-wakefulness cycle in rats after administration of (-)-LSD or BOL-148: a comparison with (+)-LSD. Br J Pharmacol (1972) 0.75
A comparison of apomorphine, bromocriptine and Sandoz CM 29-712 (6-methyl-8a-cyanomethyl-ergoline-l) in four different turning models in the rat [proceedings]. Br J Pharmacol (1978) 0.75
Turning behaviour elicited by apomorphine, (+)-amphetamine and three ergot derivatives in rats treated with a unilateral injection of ethanolamine-O-sulphate in the substantia nigra [proceedings]. Br J Pharmacol (1977) 0.75
[Clinical evaluation in geriatric psychopharmacology. The point of view of the pharmaceutical industry]. Presse Med (1983) 0.75
The antiparkinsonian activity of CQA 206-291, a new D2 dopamine receptor agonist. Clin Neuropharmacol (1989) 0.75
Neuropharmacological studies on hydergine. Triangle (1975) 0.75
[Pharmacological, pharmacokinetic and toxicological research on mesoridazine (NC 123)]. Boll Chim Farm (1967) 0.75
Effects of Hydergine and its components on Lashley maze acquisition in rats. J Pharmacol (1985) 0.75
[Involvement of serotoninergic mechanisms in the circling behaviour induced by apomorphine and LSD 25 in rats (author's transl)]. J Physiol (Paris) (1981) 0.75
Centrally acting alpha 1-adrenoceptor agonists based on hexahydronaphth[2,3-b]-1,4-oxazines and octahydrobenzo[g]quinolines. J Med Chem (1992) 0.75
Hydergine in senile mental impairment. Gerontology (1982) 0.75
Dopamine D1- and D2-receptor interaction in turning behaviour induced by dopamine agonists in 6-hydroxydopamine-lesioned rats. Neurosci Lett (1988) 0.75
Proceedings: Mechanisms involved in the effect of apomorphine on the extrapyramidal system of the rat. Naunyn Schmiedebergs Arch Pharmacol (1975) 0.75
A new semisynthetic ergot peptide alkaloid: DCN 203-922. Experientia (1987) 0.75
[Metabolism of dopamine and norepinephrine in rat brain after acute and chronic administration of haloperidol, loxapine and clozapine]. Arzneimittelforschung (1974) 0.75
Ergot alkaloids. New ergolines as selective dopaminergic stimulants. J Med Chem (1978) 0.75
Bromocriptine, dihydroergotoxine, methysergide, d-LSD, CF25--397, and 29--712: effects on the metabolism of the biogenic amines in the brain of the rat. Psychopharmacology (Berl) (1978) 0.75
SDZ PSD 958, a novel D1 receptor antagonist with potential limbic selectivity. J Neural Transm (Vienna) (1996) 0.75
Anticholinergic properties of antipsychotic drugs and their relation to extrapyramidal side-effects. Psychopharmacology (Berl) (1976) 0.75
Investigation of the influence of lithium upon the down-regulation of serotonin2 receptors in rat frontal cortex induced by long-term treatment with dibenzepin, an antidepressant without appreciable affinity to serotonin2 receptors. Naunyn Schmiedebergs Arch Pharmacol (1984) 0.75
[Effects of anticholinergics and clozapine on the activation of the striatal dopaminergic system in the rat by haloperidol. Pharmacological findings (author's transl)]. Arzneimittelforschung (1976) 0.75
Inhibition of 3H-clozapine binding in rat brain after oral administration of neuroleptics. Life Sci (1980) 0.75
Adaptive changes of the striatal dopamine system induced by repeated administration of neuroleptics and ergot derivatives. Adv Biochem Psychopharmacol (1980) 0.75
The prediction of sedative potency of neuroleptics. Mod Probl Pharmacopsychiatry (1970) 0.75
Biochemical methods for predicting the occurrence of tardive dyskinesia. Commun Psychopharmacol (1979) 0.75
Changes in the rat electrocorticogram following administration of two dihydrogenated ergot derivatives. Gerontology (1978) 0.75
Pharmacological profile of the abeorphine 201-678, a potent orally active and long lasting dopamine agonist. Life Sci (1986) 0.75
Effect of clozapine on the metabolism of serotonin in rat brain. Acta Vitaminol Enzymol (1975) 0.75
Stimulants in senility: a neglected therapeutic option? Pharmacopsychiatry (1984) 0.75
Co-dergocrine. Lancet (1986) 0.75
Neuropharmacology of bromocriptine and dihydroergotoxine (hydergine). Adv Biochem Psychopharmacol (1980) 0.75
Clozapine and the dopamine hypothesis of schizophrenia, a critical appraisal. Pharmakopsychiatr Neuropsychopharmakol (1975) 0.75
Central dopamine receptors. Postgrad Med J (1981) 0.75
The neuroleptics. 3. Pharmacology. Introduction. Mod Probl Pharmacopsychiatry (1970) 0.75
[Modification of neurotransmission in cerebral infarct (review)]. Agressologie (1982) 0.75
Effects of dihydrogenated ergot alkaloids on the sleep-wakefulness cycle and on brain biogenic amines in the rat. Arzneimittelforschung (1976) 0.75
Lack of effect of bromocriptine on the activity of monoamine oxidase in rat brain. J Pharm Pharmacol (1978) 0.75
[Effects of anticholinergics and clozapine on the activation of the striatal dopaminergic system in the rat by haloperidol. Neurochemical findings (author's transl)]. Arzneimittelforschung (1976) 0.75
Correlation between 3H-haloperidol binding in the striatum and brain amine metabolism in the rat after treatment with neuroleptics. Life Sci (1978) 0.75